Lars Køber

Showing 1-9 of 9 articles

Myocardial damage after ST-segment elevation myocardial infarction by use of bivalirudin or heparin: a DANAMI-3 substudy

Schoos M, Nepper-Christensen L, Ahtarovski K, Kyhl K, Göransson C, Holmvang L, Kelbæk H, Helqvist S, Høfsten D, Køber L, Vejlstrup N, Lønborg J, Engstrøm T

April 3, 2020 | 10.4244/EIJ-D-19-00623

Coronary interventions

Myocardial Damage After ST-Segment Elevation Myocardial Infarction According to the Use of Bivalirudin or Heparin A Cardiac Magnetic Resonance Substudy of the DANAMI3 trial

Schoos M, Nepper-Christensen L, Ahtarovski KA, Kyhl K, Göransson C, Holmvang L, Kelbæk H, Helqvist S, Høfsten D, Køber L, Vejlstrup N, Lønborg J, Engstrøm T

December 17, 2019 | 10.4244/EIJ-D-19-00623

Coronary interventions

Fractional Flow Reserve Guided PCI in Patients With and Without Left Ventricular Hypertrophy: a DANAMI-3-PRIMULTI Sub-study

Sabbah M, Nepper-Christensen L, Lønborg J, Helqvist S, Køber L, Høfsten D, Ahtarovski K, Göransson C, Kyhl K, Schoos M, Vejlstrup N, Kelbæk H, Engstrøm T

November 20, 2019 | 10.4244/EIJ-D-19-00577

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted H, Raungaard B, Jørgensen E, Køber L, Høfsten D, Kelbæk H, Engstrøm T

June 20, 2019 | 10.4244/EIJ-D-18-00766

STEMI

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy

Nepper-Christensen L, Lønborg J, Hofsten D, Ahtarovski K, Kyhl K, Göransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T

August 24, 2018 | 10.4244/EIJ-D-17-00857

Coronary interventions

Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy

Sadjadieh G, Engstrøm T, Helqvist S, Hofsten D, Køber L, Pedersen F, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted H, Kelbæk H, Holmvang L

November 20, 2016 | 10.4244/EIJV12I10A203

Coronary interventions

Acute myocardial infarction and lesion location in the left circumflex artery: importance of coronary artery dominance

Waziri H, Jørgensen E, Kelbæk H, Fosbøl E, Pedersen F, Mogensen U, Gerds T, Køber L, Wachtell K

July 20, 2016 | 10.4244/EIJY15M09_04

Coronary interventions

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker H, Clemmensen P, Køber L, Treiman M, Engstrøm T

July 20, 2016 | 10.4244/EIJV12I4A78

Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study

Kelbæk H, Engstrøm T, Ahtarovski K, Lønborg J, Vejlstrup N, Pedersen F, Holmvang L, Helqvist S, Saunamäki K, Jørgensen E, Clemmensen P, Kløvgaard L, Tilsted H, Raungaard B, Ravkilde J, Aaroe J, Eggert S, Køber L

February 22, 2013 | 10.4244/EIJV8I10A175

Latest news

NEW ISSUE

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

June 25, 2020

NEW

Ahead of print: EAPCI Core Curriculum for PCI (2020)

July 7, 2020

Editorial

IVUS guidance during left main PCI: not if, but when and how

Akiko Maehara

July 8, 2020

NEW

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

July 6, 2020

Editorial

Left main PCI: are we giving the kiss the attention it deserves?

July 8, 2020

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

July 1, 2020

JAA

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Lars Køber

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke